Clinical Trial Update: A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating withdrawal effects after dosing oxycodone/naltrexone in individuals maintained on methadone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Opioid Withdrawal

Drugs mentioned

• Oxycodone/Naltrexone (oxycodone/naltrexone)

Snippet

Sponsor: Elite Laboratories, Inc | Conditions: Withdrawal Symptoms | Phase 3 | Status: COMPLETED